Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
about
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events.Targeted inhibition of coagulation: oral agents show promise in phase III trials.Rivaroxaban: future in anticoagulation practice?Review article: thromboprophylaxis after total hip replacement.Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.
P2860
Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Influence of the duration of f ...... wing major orthopedic surgery.
@en
Influence of the duration of fondaparinux
@nl
type
label
Influence of the duration of f ...... wing major orthopedic surgery.
@en
Influence of the duration of fondaparinux
@nl
prefLabel
Influence of the duration of f ...... wing major orthopedic surgery.
@en
Influence of the duration of fondaparinux
@nl
P2093
P1476
Influence of the duration of f ...... wing major orthopedic surgery.
@en
P2093
P2860
P304
P356
10.1046/J.1538-7836.2003.00104.X
P577
2003-02-01T00:00:00Z